Glenmark Pharmaceuticals has received final USFDA approval market Hydrocortisone Valerate ointment in US markets. The ointment is used to treat a variety of skin conditions which is a generic version of Westcort Ointment, 0.2 per cent, of Sun Pharmaceutical Industries Inc.
According to market estimates, annuals sales of the ointment value is estimated at USD 11.1 million.
Company Profile : Glenmark Pharma Ltd
Leave a Reply